News
3h
Zacks.com on MSNSlowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck's Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.
Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results